Interpace Biosciences, Inc. Share Price
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Delayed
OTC Markets
17:57:22 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.660 USD | -0.60% |
|
+1.22% | +34.94% |
| Market Cap | 46.26M 40.1M 37.59M 34.27M 64.49M 4.42B 65.52M 443M 173M 2.21B 174M 170M 7.37B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 44.94M 38.95M 36.52M 33.29M 62.65M 4.29B 63.65M 430M 168M 2.15B 169M 165M 7.16B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.60% | ||
| 1 week | +1.22% | ||
| Current month | +9.43% | ||
| 1 month | +10.67% | ||
| 3 months | -12.63% | ||
| 6 months | -10.27% | ||
| Current year | +34.94% |
| 1 week | 1.61 |  | 1.7 |
| 1 month | 1.34 | | 1.7 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.77 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.33 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 30/11/2020 |
| Director of Finance/CFO | 34 | 20/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 20/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 31/12/2015 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 21/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/01/26 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 20/01/26 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 01/02/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.60% | +1.22% | +91.31% | +1.84% | 46.26M | |
| -2.18% | +16.45% | +95.97% | +443.03% | 45.54B | |
| -0.37% | +1.77% | +18.19% | +47.77% | 26.23B | |
| +0.45% | +0.67% | -19.94% | -34.39% | 7.8B | |
| -0.36% | +12.94% | +12.53% | +143.31% | 6.06B | |
| +0.77% | +4.31% | +20.91% | +71.31% | 3.42B | |
| -3.54% | +14.05% | -35.53% | +1,420.50% | 2.46B | |
| -0.21% | +5.33% | +162.66% | +17.58% | 2.11B | |
| +0.89% | +9.86% | +0.79% | -51.68% | 2.08B | |
| +9.25% | +5.04% | +29.85% | +21.18% | 1.92B | |
| Average | +0.42% | +7.64% | +37.67% | +208.04% | 9.77B | |
| Weighted average by Cap. | -0.91% | +9.38% | +52.82% | +263.51% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.68M 38.13M 34.77M 65.42M 4.48B 66.47M 449M 175M 2.24B 176M 172M 7.48B | 38.73M 33.57M 31.47M 28.69M 53.99M 3.7B 54.85M 371M 145M 1.85B 145M 142M 6.17B |
| Net income | 6.7M 5.81M 5.45M 4.97M 9.34M 640M 9.49M 64.12M 25.03M 320M 25.16M 24.62M 1.07B | 24.58M 21.3M 19.97M 18.21M 34.26M 2.35B 34.81M 235M 91.79M 1.17B 92.26M 90.26M 3.92B |
| Net Debt | 4.4M 3.81M 3.57M 3.26M 6.13M 419M 6.23M 42.05M 16.42M 210M 16.5M 16.14M 700M | -1.32M -1.15M -1.07M -979K -1.84M -126M -1.87M -12.65M -4.94M -63.16M -4.96M -4.86M -211M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/08/26 | US$1.660 | -0.60% | 14,500 |
| 12/08/26 | US$1.670 | +0.06% | 2,103 |
| 11/08/26 | US$1.669 | -1.82% | 18,248 |
| 10/08/26 | US$1.700 | +5.59% | 13,703 |
| 07/08/26 | US$1.610 | -1.83% | 501 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
